Clinical Trials at Sinai Hospital of Baltimore

As of September 2026, 51 paid clinical trials are recruiting at Sinai Hospital of Baltimore, located at 2411 W BELVEDERE AVENUE, MORTON MOWER, M.D., MOB SUITE 301, BALTIMORE, MD 21215, phone (410) 601-0500 in Baltimore, Maryland. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 24, 2026.

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

51 clinical trials at Sinai Hospital of Baltimore

·Clear filters·

Get a weekly email when new trials open in Baltimore, MD.

Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations

for Locally Advanced Pancreatic Adenocarcinoma

Sites in Baltimore, Randallstown +270 more locations

Sponsor: SWOG Cancer Research Network

Sex: All·Age: 18+

Code: NCT06998940·Phase 3·Recruiting·Listed May 2025

Apply to this trial

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

for Stage I Breast Cancer

Sites in Baltimore, Towson +705 more locations

Sponsor: NRG Oncology

Sex: All·Age: 50 - 70

Code: NCT04852887·Phase 3·Recruiting·Listed Apr 2021

Apply to this trial

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

for Breast Carcinoma

Sites in Baltimore, Towson +462 more locations

Sponsor: Wake Forest University Health Sciences

Sex: All·Age: 18+

Code: NCT06418204·Recruiting·Listed May 2024

Apply to this trial

A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study

for Hematopoietic and Lymphatic System Neoplasm

Sites in Baltimore, Bethesda +74 more locations

Sponsor: Children's Oncology Group

Sex: All·Age: 15 - 20

Code: NCT06410209·Phase 2·Recruiting·Listed May 2024

Apply to this trial

An International, Multicenter, Prospective Registry on Post-traumatic Long Bones Defects

for Limb Fracture

Sites in Baltimore +1 more location

Sponsor: AO Innovation Translation Center

Sex: All·Age: 18+

Code: NCT04112992·Recruiting·Listed Oct 2019

Apply to this trial

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

for Hodgkin Lymphoma in Remission

Sites in Baltimore +55 more locations

Sponsor: Children's Oncology Group

Sex: All·Age: All ages

Code: NCT01790152·Recruiting·Listed Feb 2013

Apply to this trial

Prospective Functional, Gait, and Outcome Comparison Study of Medial Pivot Versus Single Radius Design for Total Knee Arthroplasty

for Osteoarthritis, Knee

1 location in Baltimore

Sponsor: LifeBridge Health

Sex: All·Age: 18 - 75

Code: NCT04814082·Recruiting·Listed Mar 2021

Apply to this trial

Platelet Rich Plasma Versus Corticosteroids in Hip Osteoarthritis Pain

for Hip Osteoarthritis

1 location in Baltimore

Sponsor: LifeBridge Health

Sex: All·Age: 21 - 80

Code: NCT06793982·Phase 4·Recruiting·Listed Jan 2025

Apply to this trial

The Pericapsular Nerve Block in Total Hip Arthroplasty

for Hip Osteoarthritis

1 location in Baltimore

Sponsor: LifeBridge Health

Sex: All·Age: 18 - 80

Code: NCT04729686·Phase 4·Recruiting·Listed Jan 2021

Apply to this trial

A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

for Rhabdomyosarcoma

Sites in Baltimore +84 more locations

Sponsor: Children's Oncology Group

Sex: All·Age: Up to 50

Code: NCT07466316·Phase 3·Recruiting·Listed Mar 2026

Apply to this trial

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

for Endometrial Carcinoma

Sites in Baltimore, Westminster +325 more locations

Sponsor: National Cancer Institute (NCI)

Sex: Female·Age: 18+

Code: NCT05256225·Phase 3·Recruiting·Listed Feb 2022

Apply to this trial